270 related articles for article (PubMed ID: 36497115)
1. CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated β-Catenin Pathway.
Qi Y; Wang H; Zhang Q; Liu Z; Wang T; Wu Z; Wu W
Cells; 2022 Nov; 11(23):. PubMed ID: 36497115
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
4. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth.
Liu G; Yang ZF; Sun J; Sun BY; Zhou PY; Zhou C; Guan RY; Wang ZT; Yi Y; Qiu SJ
Cell Oncol (Dordr); 2022 Dec; 45(6):1435-1449. PubMed ID: 36435866
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis.
Liu C; Ren C; Guo L; Yang C; Yu Q
Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of cancer-associated fibroblast exosome-derived miR-29b-1-5p restrains vasculogenic mimicry and apoptosis while accelerating migration and invasion of gastric cancer cells via immunoglobulin domain-containing 1/zonula occluden-1 axis.
Wu C; Li D; Cheng X; Gu H; Qian Y; Feng L
Cell Cycle; 2023 Sep; 22(17):1807-1826. PubMed ID: 37587724
[No Abstract] [Full Text] [Related]
7. Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.
Ding B; Lou W; Fan W; Pan J
Environ Toxicol; 2023 May; 38(5):1038-1052. PubMed ID: 36722453
[TBL] [Abstract][Full Text] [Related]
8. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt/β-catenin signaling and homologous recombination.
Wen J; Xiong K; Aili A; Wang H; Zhu Y; Yu Z; Yao X; Jiang P; Xue L; Wang J
Theranostics; 2020; 10(12):5322-5340. PubMed ID: 32373215
[No Abstract] [Full Text] [Related]
9. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
[TBL] [Abstract][Full Text] [Related]
10. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
[TBL] [Abstract][Full Text] [Related]
11. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts-derived exosome-mediated transfer of miR-345-5p promotes the progression of colorectal cancer by targeting CDKN1A.
Shi W; Liu Y; Qiu X; Yang L; Lin G
Carcinogenesis; 2023 Jun; 44(4):317-327. PubMed ID: 37052230
[TBL] [Abstract][Full Text] [Related]
13. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling.
Wen J; Huang Z; Wei Y; Xue L; Wang Y; Liao J; Liang J; Chen X; Chu L; Zhang B
Cell Mol Biol Lett; 2022 Sep; 27(1):79. PubMed ID: 36138344
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
15. Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis.
Lu L; Huang J; Mo J; Da X; Li Q; Fan M; Lu H
Cell Mol Biol Lett; 2022 Feb; 27(1):17. PubMed ID: 35193488
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3.
Wang X; Wei P; Yang L; Liu F; Tong X; Yang X; Su L
Chin Med J (Engl); 2022 Sep; 135(17):2089-2097. PubMed ID: 35143426
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
[TBL] [Abstract][Full Text] [Related]
19. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
